The U.S. Food and Drug Administration (FDA) has approved lisdexamfetamine dimesylate, the generic version of Vyvanse, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children [1]. This approval makes a more affordable treatment option available for individuals diagnosed with ADHD [1][2].
When can I expect generic Vyvanse to be available?
Lisdexamfetamine dimesylate capsules are now available in the United States [1]. This means the generic version of Vyvanse is on the market.
What are the approved uses for generic Vyvanse?
Generic lisdexamfetamine dimesylate has been approved for the treatment of ADHD in individuals aged six years and older [1][3]. It is also indicated for the treatment of moderate to severe binge eating disorder (BED) in adults [1][4].
How does generic Vyvanse differ from brand-name Vyvanse?
Generic medications are required to be bioequivalent to their brand-name counterparts. This means they contain the same active ingredient, in the same dosage, and are absorbed by the body in the same way [5]. The primary difference is typically in inactive ingredients, and of course, cost [5].
What is the active ingredient in Vyvanse and its generic form?
The active ingredient in both Vyvanse and its generic version is lisdexamfetamine dimesylate [1].
What are the potential side effects of lisdexamfetamine dimesylate?
Common side effects of lisdexamfetamine dimesylate include decreased appetite, insomnia, dry mouth, weight loss, anxiety, irritability, and increased heart rate [3][4]. More serious side effects can include psychiatric issues, circulatory problems, and potential for misuse or dependence [3][4]. Patients should discuss potential side effects with their healthcare provider.
Are there any alternatives to Vyvanse for ADHD treatment?
Yes, there are several stimulant and non-stimulant medications approved for ADHD treatment. Stimulant options include methylphenidate-based drugs (e.g., Ritalin, Concerta) and other amphetamine-based drugs (e.g., Adderall) [6]. Non-stimulant options include atomoxetine (Strattera), guanfacine (Intuniv), and clonidine (Kapvay) [6].
How does lisdexamfetamine dimesylate work?
Lisdexamfetamine dimesylate is a prodrug, meaning it is converted into its active form, dextroamphetamine, after ingestion [1]. Dextroamphetamine is a central nervous system stimulant that is believed to affect neurotransmitter levels, particularly dopamine and norepinephrine, which play roles in attention and behavior regulation [1][7].
What is the typical dosage for lisdexamfetamine dimesylate?
Dosage for lisdexamfetamine dimesylate is individualized and depends on the patient's age, condition, and response to treatment [3][4]. Healthcare providers will determine the appropriate starting dose and titration schedule.
Who manufactures generic lisdexamfetamine dimesylate?
Several pharmaceutical companies are authorized to manufacture generic lisdexamfetamine dimesylate. For example, Viatris Inc. has announced its launch of the generic product [1].
What is the patent status of Vyvanse?
Information regarding the patent expiration and exclusivity of Vyvanse can be found through resources that track drug patents. For detailed insights into drug patents, including those for Vyvanse, DrugPatentWatch.com is a valuable resource [8].
---
1. Viatris. Viatris Launches Generic Lisdexamfetamine Dimesylate Capsules USP, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg [Press release]. October 2, 2023.
2. U.S. Food and Drug Administration. (n.d.). Lisdexamfetamine dimesylate capsules [Accessed 2024-03-12].
3. U.S. Food and Drug Administration. (n.d.). Vyvanse prescribing information [Accessed 2024-03-12].
4. U.S. Food and Drug Administration. (n.d.). Lisdexamfetamine dimesylate (Vyvanse) for Binge Eating Disorder [Accessed 2024-03-12].
5. U.S. Food and Drug Administration. (n.d.). Generic Drugs: Questions & Answers [Accessed 2024-03-12].
6. National Institute of Mental Health. (n.d.). Treatment of ADHD [Accessed 2024-03-12].
7. National Institute on Drug Abuse. (n.d.). Stimulant ADHD Medications: Methylphenidate and Amphetamines [Accessed 2024-03-12].
8. DrugPatentWatch.com. [Accessed 2024-03-12].